Abstract. The role of brain monoamines (5-HT, NA 
DA) in the secretion of adrenocorticotrophic hormone (ACTH) was studied in view of contradictory reports. Plasma corticosterone levels and the rate of synthesis of corticosterone in vitro by the adrenal gland were estimated in albino rats and have been taken as the index of ACTH activity. These estimations were done in unstressed and stressed, and in untreated and treated rats.
Drugs were administered intracerebroventricularly to the rats to cause selective degeneration of tryptaminer- The results show that plasma corticosterone levels and the rate of synthesis of corticosterone were significantly decreased after selective degeneration of tryptaminergic neurons in unstressed rats. After selective degeneration of either tryptaminergic or noradrenergic neurons, the acute increase in the plasma corticosterone levels and rate of synthesis of corticosterone in vitro by adrenal glands in stressed rats were significantly inhibited. These results have been interpreted to suggest that the central tonic control on adrenal glands may be 5-HT mediated and that during stress ACTH secretion may be both 5-HT and NA mediated. DA does not seem to have significant role in the regulation of ACTH secretion.
The literature on the role of brain biogenic amines in the secretion of adrenocorticotrophic hormone (ACTH) is contradictory. Brain noradrenaline (NA) has been reported either to stimulate (Kawa et al. 1978) , inhibit Scapagnini et al. 1972 ; Scapagnini & Preziosi 1973; Jones et al. 1976; Oishi 1979) or to have no effect (Schaepdrijver et (Kaplanski et al. 1974) or inhibit (Scapagnini et al. 1970 ) ACTH secretion. Similarly brain 5-hydroxytryptamine (5-HT) has been reported either to stimulate (Jones et al. 1976 ), inhibit (Ulrich et al. 1975 ; Telegdy & Vermes 1976) or to have no effect (Bhattacharya & Marks 1970; Dixit 1971 ) on ACTH secretion. 5-HT has also been reported to play an important role in the maintenance of the circadian rhythm of corticoids ; Van Delft et al. 1973) . Dopamine (DA) has been reported either to inhibit (Van Loon et al. 1971; Ulrich & Yuwiler 1973) or to have no effect (Kawa et (Neff et al. 1977) . Experiments were conducted 72 h after 6-OH-DA injection.
Brain monoamines (5-HT, NA and DA) were esti¬ mated in unstressed rats by a modified method based on the methods of Ansell 8c Beeson (1968) and Haubrich & Denzer (1973) in untreated and treated (as above) ani¬ mals. Animals were sacrificed by decapitation at appro¬ priate times after pre-treatment; the sacrifice was always between 12.00-13.00 h. All operations were carried out at 4°C. Brain tissue was homogenised in 10 ml of acidi¬ fied butanol and centrifuged. Four ml of homogenate was taken and 10 ml of n-heptane and 5 ml of 0.003 N HC1 were added to it. The mixture was shaken for 5 min and centrifuged for 10 min. Four Effect of 5,6-dihydroxytryptamine (DHT, 75 (ig/rat icv), methyl ester of parachlorophenylalanine (PCPA, 100 (ig/rat icv for 3 days), and 6-hydroxydopamine 200 Hg/rat icv) in benztropine (Benz, 25 mg/kg ip) and desmethylimipramine (DMI, 25 Effect of 5,6-dihydroxytryptamine (DHT, 75 |ig/rat icv), methyl ester of parachlorophenylalanine (PCPA, 100 ug/rat icv for 3 days), and 6-hydroxydopamine (6-OH-DA, 200 Ug/rat icv) after benztropine (Benz, 25 .
The preliminary results showed a highly significant (P < 0.001) increase in plasma corticosterone levels in rats sacrificed immediately after immobilisation ('O'h) of the animals compared to the unstressed group. The corticosterone level thereafter showed no significant change up to 2 h of immobilisation. For further studies in the present series, animals were therefore administered 35 mg/kg, ip, of pentobaribitone immediately after im¬ mobilisation and blood was collected in a heparinised tube and adrenal glands were removed for analysis. Control animals were not subjected to immobilisation but they also received the same dose of pentobarbitone. Plasma corticosterone and its rate of synthesis by the adrenal gland in vitro were estimated in both untreated and treated groups of rats and also in unstressed and stressed animals in similar untreated and treated groups.
Results

Brain monoamines
Pre-treatment with DHT and PCPA decreased the whole brain 5-HT level by 46.6% and 54.55%, respectively, compared to the vehicle treated chronically cannulated control group. In Benz-6-OH-DA treated rats, whole brain NA levels were found to be significantly decreased (42.5%) com¬ pared to similarly administered vehicle treated group with no significant change in DA and 5-HT levels. In DMI-6-OH-DA treated rats, whole brain DA levels were found to be significantly decreased (46.25%) compared to the vehicle treated group with no significant change in NA and 5-HT level.
The results are summarized in Table 1 .
Plasma corticosterone
In unstressed rats, plasma cortisterone levels were significantly decreased after pre-treatment with either DHT or PCPA, and not significantly affec¬ ted in either Benz-6-OH-DA or DMI-6-OH-DA groups. Stress caused a significant (P < 0.001) in¬ crease in plasma corticosterone levels in the untrea¬ ted group of rats. This increase in plasma cortico¬ sterone levels in stressed rats were significantly inhibited in animals pre-treated with DHT, PCPA and Benz-6-OH-DA, but not in the group pretreated with DMI-6-OH-DA. The results are sum¬ marized in Table 2 . Effect of 5,6-dihydroxytryptamine (DHT, 75 p.g/rat icv), and 6-hydroxydopamine (6-OH-DA, 200 ug/rat icv) after benztropine (Benz, 25 (Table 4) . (Amar & Sanyal, unpublished data 
